Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia

Written by Customer Service on August 16, 2021. Posted in Public Companies.

MELBOURNE, Australia and LONDON , Aug. 17, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the London-based Great Ormond Street Hospital (GOSH) has received UK research ethics approval to commence a Phase II academic study of Telix’s investigational product, TLX66 (90Y-DTPA-besilesomab), in children with high-risk leukemia. Relevant approvals from the Medicines and Healthcare products Regulatory Agency (MHRA), and Administration of Radioactive Substances Advisory Committee (ARSAC) have also been received. The study is independently funded by the generosity of a philanthropic foundation, with GOSH as the sponsor. The open label Phase II study is being carried out by GOSH to evaluate safety and efficacy of TLX66 as part of a reduced toxicity conditioning regimen in children...

PyroGenesis Announces Q2 2021 Results Revenues $8.3MM; Gross Margin 59.6%; Current Backlog $32.1MM

Written by Customer Service on August 16, 2021. Posted in Earnings Releases And Operating Results.

MONTREAL, Aug. 16, 2021 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (NASDAQ: PYR) (TSX: PYR) (FRA: 8PY), a high-tech Company (hereinafter referred to as the “Company” or “PyroGenesis”), that designs, develops, manufactures and commercializes advanced plasma processes and sustainable solutions to reduce greenhouse gases (GHG), is pleased to announce today its financial and operational results for the second quarter ended June 30th, 2021. “We are happy to be announcing financial results for Q2 2021 and, once again, they are historical. As can be seen from the table below, net income from operations (not including share-based expenses) was profitable at $850K, on record quarterly revenues of $8.3MM (a 32% increase Q1 over Q2 2021). This is the fourth quarter in a row that PyroGenesis has posted more revenues...

Alcanna Reports Second Quarter Financial Results

Written by Customer Service on August 16, 2021. Posted in Earnings Releases And Operating Results.

EDMONTON, Alberta, Aug. 16, 2021 (GLOBE NEWSWIRE) — Alcanna Inc. (the “Company” or “Alcanna”) (TSX: CLIQ) today reported its financial results for the three and six months ended June 30, 2021. Second Quarter Financial Results and Business Update For the second quarter of 2021, Alcanna’s same-store liquor sales from continuing operations of $158.9 million was essentially equal to the increased sales realized for Q2 2020 during the initial months of the COVID-19 pandemic of $159.8 million. Compared to Q2 2019 (pre COVID-19 pandemic), same-store liquor sales in Q2 2021 increased by 10.6%. Since late March 2020, the Company’s liquor retail sales have been positively impacted due to a shift in customer consumption habits resulting from the COVID-19 pandemic, where customers shifted away from on-premise alcohol consumption establishments,...

KnowBe4 Announces Closing of Follow-On Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Written by Customer Service on August 16, 2021. Posted in Public Companies.

TAMPA BAY, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) — KnowBe4, Inc. (“KnowBe4”) (Nasdaq: KNBE) today announced the closing of its previously announced underwritten public offering of 11,995,546 shares of its Class A common stock by certain selling stockholders at a price to the public of $20.75 per share, which includes the full exercise of the underwriters’ option to purchase 1,564,636 shares of KnowBe4’s Class A common stock from the selling stockholders. The offering was upsized from a previously announced offering size of 8,719,740 shares. KnowBe4 will not receive any proceeds from any sales of shares by the selling stockholders. Morgan Stanley, Goldman Sachs & Co. LLC, BofA Securities and KKR Capital Markets, LLC acted as lead bookrunners for the offering. Citigroup acted as an additional bookrunner for the offering....

W. R. Grace Holdings LLC and W. R. Grace & Co.-Conn. Announce Results of Early Participation in Exchange Offers and Consent Solicitations

Written by Customer Service on August 16, 2021. Posted in Public Companies.

NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) — W. R. Grace Holdings LLC (formerly known as Gibraltar Acquisition Holdings LLC) (“Holdings”) and W. R. Grace & Co. (NYSE: GRA) (“Grace”) today announced that, in connection with the previously announced offers to eligible holders to exchange (each, an “Exchange Offer” and collectively, the “Exchange Offers”) any and all outstanding notes issued by W. R. Grace & Co.-Conn. (the “Grace Issuer”) as set forth in the table below (the “Existing Grace Notes”) for (1) up to $1,050,000,000 aggregate principal amount of new notes issued by Holdings (the “New Secured Notes”) and (2) cash, and related consent solicitations (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”) to adopt certain proposed amendments to each of the indentures governing the Existing Grace...

Euro Manganese files Q3 financial statements and MD&A and provides financial and operational highlights

Written by Customer Service on August 16, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 16, 2021 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF) (the “Company” or “EMN“) today filed its third quarter financial statements and management’s discussion and analysis (“MD&A”) and is pleased to provide the following financial and operating highlights for the quarter: On May 10, 2021, the Company completed the second tranche of a two-tranche brokered private placement of 50 million CHESS Depository Interests (“CDIs”), with each CDI representing one common share, at a price of AUD0.60 for aggregate gross proceeds of AUD30.0 million ($28.6 million) and net proceeds of AUD28.5 million ($27.2 million). Accordingly, the Company ended the quarter with $33.8 million in cash and $27.8 million in working capital. On May 31, 2021, the Company...

WestBond Increases Sales for the Quarter ended June 30, 2021 and Temporarily Suspends Quarterly Dividend

Written by Customer Service on August 16, 2021. Posted in Dividend Reports And Estimates.

DELTA, British Columbia, Aug. 16, 2021 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) has posted a profit of $69,688 ($0.002 per share) for the three months ended June 30, 2021, compared to a loss of $2,814 ($0.000 per share). Sales were $2,708,491 for the three months ended June 30, 2021 which is 38.5% higher than for the three months ended June 30, 2020 and 4.2% higher than the three months ended March 31, 2021. The quarterly dividend has been suspended temporarily until sales and profitability improve with the expansion of our disinfectant wet-wipes and other products. The quarterly report and other information are available on the company’s website at www.westbond.ca and on SEDAR at www.sedar.com. For further information please contact: Gennaro Magistrale Chief Executive Officer, President and DirectorWestBond...

Ayr Wellness Reports Second Quarter 2021 Results

Written by Customer Service on August 16, 2021. Posted in Earnings Releases And Operating Results.

Q2 Revenue up 222% Y/Y to $91.3 Million, up 56% sequentially Q2 Adjusted EBITDA of $27.4 million on a US GAAP basis, up 225% Y/Y and 49% sequentially US GAAP Operating Loss of $24.9 Million Included Non-Cash, One-Time Expenses, and Non-Operating Adjustments totaling $52.3 Million Increasing 2022 Revenue Target to $800 Million, with $300 Million of AEBITDA Reflecting Substantial Investments in Growth Company Provides 3Q21 Guidance for a targeted $100 Million in Revenue, up Over 211% Y/Y and 10% Q/Q, with Adjusted EBITDA Flat Sequentially Over Q2 Announced Three Proposed Acquisitions, Including Levia, the Leading Branded Cannabis Beverage Company, Adding Illinois as Eighth State and Significantly Expanding Cultivation Capacity in Nevada NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF)...

Field Trip Health Ltd. Reports Fiscal First Quarter 2022 Financial Results

Written by Customer Service on August 16, 2021. Posted in Earnings Releases And Operating Results.

At June 30, 2021 had approximately $100 million in unrestricted cash and cash equivalents, funds held in trust and short-term investments Development of FT-104, a novel psychedelic molecule with pending patents, continues to progress with GMP production achieved The Company remains on track to meet milestone of 20 sites open or under construction by December 2021 TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; Nasdaq: FTRP) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, reported its fiscal first quarter 2022 results for the three months ended June 30, 2021. All results are reported under International Financial Reporting Standards (“IFRS”) and in Canadian dollars, unless otherwise specified. Key Highlights and Developments During...

Dril-Quip, Inc. Wins OTC Spotlight on New Technology Award for BADGeR™ Specialty Connector

Written by Customer Service on August 16, 2021. Posted in Public Companies.

HOUSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) — Dril-Quip, Inc. (NYSE: DRQ) (the ‘Company’ or ‘Dril-Quip’) announced that it was presented with a Spotlight on New Technology Award by the 2021 Offshore Technology Conference (OTC) today for its BADGeR™ Specialty Casing Connector. The BADGeR™ is a high-performance, gas tight casing connector that features superior fatigue performance and anti-rotation keys to allow for hands-free make-up. These benefits provide quicker connection times and allow for fewer rig personnel working in the high risk red zone, making the BADGeR™ another product in Dril-Quip’s “e-Series” that reduces risks and costs for the customer. Blake DeBerry, Dril-Quip’s Chief Executive Officer, remarked, “This most recent Spotlight on New Technology Award from OTC for the BADGeR™ demonstrates our commitment to deliver...

Day: August 16, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice